Crovalimab
Chugai Pharmaceutical
['commodore ', 'rova,(-approval)', '4654', 'rova,(-approval),(-microvascular)', 'dance', 'imab ']
phase 3 crovalimab study (commodore 3): in complement inhibitor-naive pts with pnh paper 292. china study. #ash22 
Clinical Haematologist, marrow transplanter. Past President World WMDA and WBMT. Editor-in-Chief Internal Medicine Journal.